Skip to main content

COVID-19 clinical trials at University of California Health

47 in progress, 22 open to eligible people

Showing trials for
  • Pilot rTMS Trial for Neuropsychiatric Symptoms of Long-COVID

    open to eligible people ages 18 years and up

    This is a pilot randomized trial of rTMS for symptoms of fatigue and brain fog, and other neuropsychiatric symptoms of Long-COVID (Post-COVID, post-acute sequelae of COVID-19 infection, PASC). Twenty participants diagnosed with Long-COVID and…

    at UCLA

  • Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients

    open to eligible people ages 18 years and up

    Immunocompromised individuals, such as solid organ transplant (SOT) recipients are at high risk of COVID-19 associated complications and mortality. Retrospective studies so far have shown that a majority of SOT recipients did not develop appreciable …

    at UC Davis

  • I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

    open to eligible people ages 18 years and up

    The goal of this project is to rapidly screen promising agents, in the setting of an adaptive platform trial, for treatment of critically ill COVID-19 patients. In this phase 2 platform design, agents will be identified with a signal suggesting a…

    at UC Davis UC Irvine UCSF

  • CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19

    open to eligible people ages 18 years and up

    The goal of this proof-of-concept clinical trial is to determine whether cardiac rehabilitation improves exercise capacity and chronotropic (heart rate) response to exercise among people with Long COVID. The study will include individuals with…

    at UCSF

  • Community-engaged Optimization of COVID-19 Rapid Evaluation and TEsting Experiences

    open to all eligible people

    Throughout the Coronavirus disease (COVID-19) pandemic, rates of COVID-19 have been persistently high in San Diego County's central and southern communities near the United States/Mexico border. These regions predominantly house Latino residents,…

    at UCSD

  • Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use

    open to eligible people ages 18 years and up

    The study consists of a randomized controlled trial evaluating the efficacy and feasibility of a stepped alcohol treatment using telemedicine on unhealthy alcohol use in patients with chronic liver disease receiving care in hepatology practices at…

    at UCSF

  • Exercise in Child Health

    open to eligible people ages 10-17

    This study is a cooperative investigation funded by the NIH. The project is a collaboration among three major NIH Clinical Translational Science Awardees: 1) UCI (lead site with its affiliate CHOC), 2) Northwestern University (with its affiliate…

    at UC Irvine

  • Imaging Immune Activation in COVID-19

    open to eligible people ages 18 years and up

    This is a single center, single arm exploratory imaging study involving up to two intravenous microdoses of [18F]F-AraG (the second tracer dose is optional) followed by whole-body PET-CT imaging in participants with convalescent COVID-19. Up to 80…

    at UCSF

  • DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to all eligible people

    This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection. It also contains a sub-study to enroll patients with severe COVID-19.

    at UC Davis UCLA UCSD

  • Long Haul COVID Rehabilitation & Recovery Research Program

    open to eligible people ages 18-90

    The purpose of the study is to assess the physiologic, immunologic, and mental health effects of a rehabilitation program on patients with Long Haul COVID (LHC).

    at UCLA

  • EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

    open to eligible people ages 18 years and up

    The overarching goal of this study is to determine if baricitinib, as compared to placebo, will improve neurocognitive function, along with measures of physical function, quality of life, post-exertional malaise, effect of breathlessness on daily…

    at UCSF

  • RECOVER-AUTONOMIC Platform Protocol

    open to eligible people ages 18 years and up

    This study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community settings where it can be integrated into COVID-19 programs and subsequent treatment plans. This …

    at UCSD

  • RECOVER-ENERGIZE Platform Protocol

    open to eligible people ages 18 years and up

    This is a platform protocol designed to be flexible so that it is suitable for a range of interventions and settings within diverse health care systems and community settings with incorporation into clinical COVID-19 management programs and…

    at UCLA

  • RECOVER-SLEEP: Platform Protocol

    open to eligible people ages 18 years and up

    The platform protocol is designed to be flexible so that it is suitable for a range of study settings and intervention types. Therefore, the platform protocol provides a general protocol structure that can be shared by multiple interventions and…

    at UCSF

  • Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)

    open to eligible people ages 18 years and up

    Treatments are needed to improve outcomes among patients hospitalized for COVID-19, including direct-acting antiviral (DAA) agents to mitigate the pathology driven by ongoing viral replication. This trial will evaluate S-217622 (ensitrelvir), an…

    at UC Davis UCLA UCSD UCSF

  • Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial

    open to eligible people ages 18 years and up

    COVID-19 can trigger a dysregulated immune response, and previous studies have shown that immune modulation can improve outcomes in hospitalized patients. This trial is designed to determine whether intensification of immune modulation early in the…

    at UC Davis UCLA UCSD UCSF

  • COVID-19 Outcome Prediction Algorithm

    open to eligible people ages 18 years and up

    Severe acute respiratory syndrome coronavirus 2-mediated coronavirus disease (COVID-19) is an evolutionarily unprecedented natural experiment that causes major changes to the host immune system. We propose to develop a test that accurately predicts…

    at UCLA

  • KIDney Injury in Times of COVID-19 (KIDCOV)

    open to eligible people ages 18 years and up

    There is an unmet need to evaluate the impact of sub-clinical/mild COVID19 disease in the outpatient setting on prevalent and incident renal injury, as this data is currently unavailable. To capture the diversity of race/ethnic risk and COVID19…

    at UCSF

  • Long-term Impact of Infection With Novel Coronavirus (COVID-19)

    open to eligible people ages 18-100

    LIINC is a study of volunteers who were previously infected with SARS-CoV-2 (also known as novel coronavirus or COVID-19) who have recovered from acute infection. The study is designed to provide a specimen bank of samples with carefully…

    at UCSF

  • Neural and Cognitive Consequences of COVID-19 Survival

    open to eligible people ages 18-70

    The novel coronavirus SARS-CoV-2 infection, COVID, continues to rage throughout the world with 115,000,000 confirmed cases and over 2,500,000 deaths (as of Mar 3, 2021). This translates to millions of people surviving COVID19 infection. While the…

    at UCSF

  • Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

    open to eligible people ages 0-20

    The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The…

    at UCLA

  • Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health

    open to eligible females ages 18 years and up

    The purpose of the UCSD Human Milk Biorepository is to establish and maintain a repository of breast milk samples that can be used to learn more about how breast milk influences infant and child health.

    at UCSD

  • T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses

    Sorry, not yet accepting patients

    The goal of this clinical trial is to test two investigational COVID-19 booster vaccines, called CoTend-s3BXBB and CoTend-BXBB, in healthy volunteers ages 40-64. The CoTend-s3BXBB vaccine includes a component called "s3", which was designed to…

    at UC Davis UCLA UCSF

  • EB05 + SOC Vs. Placebo + SOC in Adult Hospitalized Patients with COVID-19

    Sorry, currently not accepting new patients, but might later

    COVID-19 patients who develop severe disease often develop acute respiratory distress syndrome (ARDS) as a result of a dysregulated immune response. This in turn stimulates a pro-inflammatory cascade ("cytokine storm") as well as emergency…

    at UCSF

  • Positive Emotions With Long COVID-19

    Sorry, in progress, not accepting new patients

    This study is testing a new brief mindfulness practice for people suffering from long COVID-19 symptoms. People suffering from long COVID are particularly vulnerable to negative emotions, as they must also cope with the long-term uncertainty of…

    at UC Davis

  • PET/CT Imaging in COVID-19 Patients

    Sorry, accepting new patients by invitation only

    This is a PET/CT study using the 18F-αvβ6-binding-peptide.The goal of this study is to evaluate this peptide in patients after infection with SARS CoV2.

    at UC Davis

  • Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19)

    Sorry, in progress, not accepting new patients

    Persistent viral infection with viral reservoirs and detection of circulating spike protein after the initial acute illness is one potential pathogenic mechanism for Long COVID. This mechanism may be able to be targeted by SARS-CoV-2 monoclonal…

    at UCSF

  • Chinese Herbal Formula for COVID-19

    Sorry, in progress, not accepting new patients

    This is a multi-center, randomized, double-blind, placebo-controlled clinical trial to evaluate a 21-herb formula named modified Qing Fei Pai Du Tang (mQFPD) to treat COVID-19-positive outpatients with mild-to-moderate symptoms assigned to…

    at UCLA UCSD

  • Cognitive Rehabilitation Therapy for COVID-19

    Sorry, accepting new patients by invitation only

    Cognitive dysfunction, psychiatric symptoms, functional impairment, and disability following COVID-19 negatively impact Veterans' community functioning and quality of life, contribute to significant human suffering, and are costly to VHA.…

    at UCSD

  • COVID Protection After Transplant - Sanofi GSK (CPAT-SG) Study

    Sorry, in progress, not accepting new patients

    An open label, non-randomized pilot study in kidney transplant recipients who received a completed primary series and bivalent booster of mRNA based COVID-19 vaccine and have =<2500 U/mL SARS-CoV-2 S antibody concentration using the Roche Elecsys(R) …

    at UCSD UCSF

  • IgPro20 in Post-COVID-19 POTS

    Sorry, not currently recruiting here

    This is a prospective, phase 3, multicenter, double-blind, randomized placebo-controlled study to investigate the efficacy, safety, and pharmacokinetics (PK) of repeat doses of IgPro20 in participants with post SARS-CoV-2 infection 2019 postural…

    at UC Irvine UCSD

  • Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID

    Sorry, in progress, not accepting new patients

    Persistent viral infection with viral reservoirs and detection of circulating spike protein after the initial acute illness is one potential pathogenic mechanism for Long COVID. This mechanism may be susceptible to antiviral therapy that blocks…

    at UCSF

  • EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

    Sorry, not currently recruiting here

    The purpose of this clinical trial is to learn about the safety, pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and eliminated from your body after you take it), and efficacy (how well a study treatment works in the…

    at UCLA

  • Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccination

    Sorry, in progress, not accepting new patients

    This study develops and evaluates the "INdividual and Family-Oriented Responsive Messaging EDucation" (INFORMED) intervention in increasing knowledge about COVID-19 testing and decreasing decisional conflicts of getting tested for COVID-19. A 2-arm…

    at UC Davis UCSF

  • Mushroom-based Product for COVID-19

    Sorry, in progress, not accepting new patients

    This is a multi-center, randomized, double-blind, placebo-controlled clinical trial to evaluate two polypore mushrooms, Fomitopsis officinalis and Trametes versicolor (FoTv), to treat COVID-19-positive outpatients with mild-to-moderate symptoms…

    at UC Irvine UCLA UCSD

  • RCT of Mushroom Based Natural Product to Enhance Immune Response to COVID-19 Vaccination

    Sorry, in progress, not accepting new patients

    This is a randomized, double-blind, placebo-controlled clinical trial to evaluate the effect of two polypore mushrooms, Fomitopsis officinalis and Trametes versicolor (FoTv), for use as an adjunct to vaccination for COVID-19 in a general population…

    at UCSD

  • Working Towards Empowered Community-driven Approaches to Increase Vaccination and Preventive Care Engagement

    Sorry, accepting new patients by invitation only

    This study will optimize, implement, and test the impact of our multicomponent health program that includes three primary implementation strategies (Cultural Weavers and co-creation, mHealth strategies using culturally meaningful text and voice…

    at UCSD

  • Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic

    Sorry, not accepting new patients

    This single arm, multicenter study provides the pertuzumab and trastuzumab fixed-dose combination formulation for subcutaneous injection (PH FDC SC) administered at home by a home health nursing provider for patients with human epidermal growth…

    at UCSF

  • ASCO Survey on COVID-19 in Oncology (ASCO) Registry

    Sorry, in progress, not accepting new patients

    The American Society of Clinical Oncology (ASCO) Survey on Coronavirus 2019 (COVID-19) in Oncology Registry (ASCO Registry) aims to help the cancer community learn more about the patterns of symptoms and severity of COVID-19 among patients with…

    at UCSF

  • Pregnancy In the CoRonavirus (COVID-19) pandEmic

    Sorry, in progress, not accepting new patients

    Prospective nationwide cohort study of pregnant women enrolled early in gestation and followed for Covid-19 exposure and infection, with follow up of obstetrical outcomes and infant development through the first year of life.

    at UCSF

  • COVID-19 Recovered Volunteer Research Participant Pool Registry

    Sorry, in progress, not accepting new patients

    This is a prospective observational registry of COVID-19 recovered patients who are no longer symptomatic. This Registry is intended to serve as a pool of individuals that can participate in studies associated with serological testing,…

    at UCLA

  • Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer

    Sorry, in progress, not accepting new patients

    This study evaluates immunologic response following COVID-19 vaccination in children, adolescents, and young adults with cancer. Vaccines work by stimulating the body's immune cells to respond against a specific disease. The immune response produces …

    at UCSF

  • Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)

    Sorry, not accepting new patients

    The primary objective of this study is to provide expanded access of remdesivir (RDV) for the treatment of severe acute respiratory syndrome coronavirus (SARS-CoV2) infection.

    at UCSF

  • Innovative Support for Patients with SARS-COV2 Infections (COVID-19) Registry (INSPIRE)

    Sorry, in progress, not accepting new patients

    The Innovative Support for Patients with SARS COV-2 Infections Registry (INSPIRE) study is a CDC-funded COVID-19 project to understand the long-term health outcomes in recently tested adults, both negative and positive, who have suspected COVID…

    at UCLA UCSF

  • NCI COVID-19 in Cancer Patients, NCCAPS Study

    Sorry, in progress, not accepting new patients

    This study collects blood samples, medical information, and medical images from patients who are being treated for cancer and have a positive test for SARS CoV-2, the new coronavirus that causes the disease called COVID-19. Collecting blood samples, …

    at UC Davis UC Irvine UCLA UCSD UCSF

  • Long-term Impact of COVID on Children and Families

    Sorry, in progress, not accepting new patients

    This is a combined retrospective and prospective, longitudinal, observational meta-cohort of individuals age 0-25 years who will enter the cohort with and without SARS-CoV-2 infection at varying stages before and after infection. Individuals with…

    at UCSD UCSF

  • Long-term Impact of COVID-19 in Adults (RECOVER)

    Sorry, in progress, not accepting new patients

    This is a combined retrospective and prospective, longitudinal, observational meta-cohort of individuals who will enter the cohort with and without SARS-CoV-2 infection and at varying stages before and after infection. Individuals with and without…

    at UCSF

Our lead scientists for COVID-19 research studies include .

Last updated: